Form 4: Elevance Health HR Chief Reports Stock, Option Changes

Elevance Health's EVP & Chief HR Officer, Ryan R. Craig, reported routine acquisitions of restricted stock units and stock options, alongside dispositions for tax liabilities.

Summary

• Ryan R. Craig, EVP & Chief HR Officer of Elevance Health, Inc. (ELV), reported changes in his beneficial ownership.
• On March 2, 2026, Craig disposed of 25 shares of common stock at $294.07 to cover tax liabilities related to restricted stock vesting.
• Also on March 2, 2026, Craig acquired 2,976 restricted share units (RSUs) at a price of $0. These RSUs will vest in three equal annual installments of 992 shares on March 2, 2027, March 2, 2028, and March 2, 2029.
• On March 3, 2026, Craig disposed of an additional 309 shares of common stock at $284.03 for tax withholding purposes related to restricted stock vesting.
• Craig also acquired 11,754 employee stock options on March 2, 2026, with an exercise price of $294.07 and an expiration date of March 2, 2036. These options become exercisable in three annual installments of 3,918 shares, starting March 2, 2027.
• Following these transactions, Craig beneficially owns 6,674 shares of common stock directly and 11,754 employee stock options directly.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing. While dispositions occurred, they were for tax purposes, and the acquisitions of RSUs and options demonstrate continued executive alignment with long-term company performance.

Positives

• The acquisition of 2,976 restricted share units (RSUs) and 11,754 employee stock options indicates continued long-term incentive alignment between the executive and shareholder interests.
• The vesting schedule for RSUs and options encourages long-term retention and performance from the EVP & Chief HR Officer.

Negatives

• Dispositions of 25 shares and 309 shares were made to cover tax liabilities, which is a common practice but reduces direct share ownership.

Risks

• No specific risks related to company operations or financial health are mentioned in this Form 4 filing, as it primarily reports insider transactions.

Future Outlook

The filing does not contain forward-looking statements regarding the company's operational or financial performance, focusing solely on insider ownership changes. The vesting schedules for RSUs and options extend into 2027, 2028, and 2029, indicating a long-term incentive structure for the executive.

Management Comments

• No direct management comments or notable quotes are provided in this Form 4 filing, which is a standard reporting document for insider transactions.

Industry Context

StockSavvy.ai notes that routine Form 4 filings, such as this one, are common in the healthcare industry for executives receiving equity-based compensation. These transactions reflect standard compensation practices rather than strategic shifts or market-moving events. Elevance Health, a major player in the health insurance sector, typically uses such incentives to align executive interests with long-term company performance, similar to peers like UnitedHealth Group (UNH) or Cigna (CI).

Comparison to Industry Standards

• The use of restricted stock units (RSUs) and employee stock options as part of executive compensation is a standard practice across the healthcare and broader corporate landscape, aligning with compensation structures seen at companies like UnitedHealth Group, CVS Health, and Humana.
• The disposition of shares to cover tax liabilities upon vesting of equity awards is a common and expected event for executives receiving such compensation, consistent with practices at most publicly traded companies.

Stakeholder Impact

• Shareholders: The acquisition of equity awards by a key executive generally aligns management's interests with shareholder value creation over the long term.
• Employees: No direct impact on general employees is indicated by this executive compensation filing.

Next Steps

• 992 restricted share units will vest on March 2, 2027.
• The first installment of 3,918 employee stock options will become exercisable on March 2, 2027.
• Additional tranches of restricted share units will vest on March 2, 2028, and March 2, 2029.

Key Dates

Recommendation

This Form 4 filing details routine insider transactions related to executive compensation, including the vesting of equity awards, tax-related dispositions, and new grants of restricted stock units and stock options. These events are standard and do not provide new information that would fundamentally alter the investment thesis for Elevance Health. The transactions reflect ongoing compensation practices and executive alignment, rather than a change in company fundamentals or strategic direction. Therefore, a 'hold' recommendation is appropriate as this filing does not present a catalyst for a 'buy' or 'sell' decision.

Keywords

Elevance Health, ELV, Form 4, Insider Trading, Restricted Stock Units, Stock Options, Executive Compensation, Beneficial Ownership, Ryan R. Craig